Today, 25% of Americans smoke and 50% of smokers die from tobacco-related illnesses. Meanwhile, little attention has been given to implementing cessation therapies for our patients who smoke. Nicotine in Psychiatry: Psychopathology and Emerging Therapeutics examines this timely subject. The book's contributors, subject matter experts in the growing field of nicotine neurobiology andclinical pharmacology, cover the latest knowledge on -The pharmacokinetics and pharmacodynamics of nicotine -The effect of nicotinic receptors on the central nervous system (CNS), the recent advances made in understanding the normal function of these receptors, and how this knowledge transfers to the clinical treatment of many CNS disorders -Behavioral factors influencing the effects of nicotine and nicotine's addictive capacity -The association between smoking and specific mental disorders and the association between nicotine and mood -Clinical applications of nicotine as a potential therapeutic agent for a variety of disorders, such as attention deficit, Alzheimer's and Parkinson's diseases, epilepsy, inflammatory bowel disease, schizophrenia, and Tourette's syndrome -Nicotine replacement therapies and various smoking-cessation strategies This book makes fascinating reading for anyone interested in the recent tobacco public policy debates, as well as clinicians and researchers looking for current information on nicotine and its clinical applications.
FREE Two-Day Shipping for students on millions of items. Learn more |
Book Description
Special Offers and Product Promotions
- Buy $50 in qualifying physical textbooks, get $5 in Amazon MP3 Credit. Here's how (restrictions apply)
Editorial Reviews
Review
"I highly recommend this book for the busy clinician." -- Journal of Clinical Psychiatry, June 2001
...We are informed and motivated by [this book's] firm roots in research and clinical practice. ... -- John N. Chappel, M.D., Professor Emeritus of Psychiatry, University of Nevada School of Medicine, Reno, Nevada
...a comprehensive view of the role of nicotine in depression, Alzheimer's and Parkinson's disease, schizophrenia, Tourette's syndrome, attention deficit disorder, and tobacco abuse... -- Robert Freedman, M.D., Professor, Departments of Psychiatry and Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado
...We are informed and motivated by [this book's] firm roots in research and clinical practice. ... -- John N. Chappel, M.D., Professor Emeritus of Psychiatry, University of Nevada School of Medicine, Reno, Nevada
...a comprehensive view of the role of nicotine in depression, Alzheimer's and Parkinson's disease, schizophrenia, Tourette's syndrome, attention deficit disorder, and tobacco abuse... -- Robert Freedman, M.D., Professor, Departments of Psychiatry and Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado
About the Author
Melissa Piasecki, M.D., is an Assistant Professor inn the Department of Psychiatry and Behavioral Sciences at the University of Nevada School of Medicine in Reno, Nevada. Paul A. Newhouse, M.D., is the Director of the Clinical Neuroscience Research Unit and Geriatric Service and Associate Professor in the Department of Psychiatry at the University of Vermont College of Medicine in Burlington, Vermont.
Product Details
Would you like to update product info or give feedback on images?
|
Customer Reviews
|
There are no customer reviews yet.
|
|||
|
Video reviews
|
Front Cover | Front Flap | Table of Contents | First Pages | Index | Back Flap | Back Cover | Surprise Me!
Inside This Book
(learn more)
First Sentence:
Although acetylcholine was identified as a peripheral neurotransmitter in the early part of the century, it was only in the late 1950s that evidence of neurotransmission within the central nervous system was produced by means of demonstration of cholinergic transmission at motor neuron-Renshaw cell synapses in the spinal cord (Curtis and Eccles 1958). Read the first page Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
nicotinic treatment, other nicotinic agonists, plasma nicotine levels, nicotine patch treatment, sensory replacement, nicotine analogues, cholinergic channel activator, nicotinic systems, chronic nicotine treatment, intravenous nicotine, nicotine skin patches, nicotinic agents, nicotine therapy, nicotinic stimulation, conditioned tolerance, nicotine effects, placebo gum, transdermal nicotine, neuronal nicotinic receptors, nicotine inhaler, nicotine gum, nicotine administration, smoking cessation treatment, nicotine metabolism, nicotine dependence Key Phrases - Capitalized Phrases (CAPs): (learn more)
New York, Pharmacol Biochem Behav, Pharmacol Exp Ther, American Psychiatric Association, United States, Brain Res, Arch Gen Psychiatry, Biol Psychiatry, Consult Clin Psychol, Acad Sci, Addict Behav, Pharmacol Ther, Ann Neurol, Arch Intern Med, Subst Abuse, World Health Organization, Mol Pharmacol, Drug Development Research, Psychopharmacol Bull, Clin Invest, Life Sci, Trends Neurosci, Alzheimer Dis Assoc Disord, Biological Systems, British Journal of Addiction New!
Books on Related Topics | Concordance | Text Stats Browse Sample Pages:
Front Cover | Front Flap | Table of Contents | First Pages | Index | Back Flap | Back Cover | Surprise Me!
Although acetylcholine was identified as a peripheral neurotransmitter in the early part of the century, it was only in the late 1950s that evidence of neurotransmission within the central nervous system was produced by means of demonstration of cholinergic transmission at motor neuron-Renshaw cell synapses in the spinal cord (Curtis and Eccles 1958). Read the first page Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
nicotinic treatment, other nicotinic agonists, plasma nicotine levels, nicotine patch treatment, sensory replacement, nicotine analogues, cholinergic channel activator, nicotinic systems, chronic nicotine treatment, intravenous nicotine, nicotine skin patches, nicotinic agents, nicotine therapy, nicotinic stimulation, conditioned tolerance, nicotine effects, placebo gum, transdermal nicotine, neuronal nicotinic receptors, nicotine inhaler, nicotine gum, nicotine administration, smoking cessation treatment, nicotine metabolism, nicotine dependence Key Phrases - Capitalized Phrases (CAPs): (learn more)
New York, Pharmacol Biochem Behav, Pharmacol Exp Ther, American Psychiatric Association, United States, Brain Res, Arch Gen Psychiatry, Biol Psychiatry, Consult Clin Psychol, Acad Sci, Addict Behav, Pharmacol Ther, Ann Neurol, Arch Intern Med, Subst Abuse, World Health Organization, Mol Pharmacol, Drug Development Research, Psychopharmacol Bull, Clin Invest, Life Sci, Trends Neurosci, Alzheimer Dis Assoc Disord, Biological Systems, British Journal of Addiction New!
Books on Related Topics | Concordance | Text Stats Browse Sample Pages:
Front Cover | Front Flap | Table of Contents | First Pages | Index | Back Flap | Back Cover | Surprise Me!
Citations (learn more)
Books on Related Topics
(learn more)
|
Tag this product(What's this?)Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items. |
Sell a Digital Version of This Book in the Kindle Store
If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store.
Learn more
Customer Discussions
|
This product's forum
Active discussions in related forums
Search Customer Discussions
|
Related forums
|
Listmania!
So You'd Like to...
Look for Similar Items by Category
- Books > Health, Fitness & Dieting > Psychology & Counseling
- Books > Health, Fitness & Dieting > Recovery > Smoking
- Books > Medical Books > Medicine > Internal Medicine
- Books > New & Used Textbooks > Medicine & Health Sciences > Medicine > Clinical > Neurology
- Books > New & Used Textbooks > Medicine & Health Sciences > Medicine > Clinical > Psychiatry
- Books > New & Used Textbooks > Social Sciences > Psychology > Psychotherapy
